Literature DB >> 18226565

The treatment of isolated iliac artery aneurysm in patients with non-aneurysmal aorta.

W Dorigo1, R Pulli, N Troisi, A Alessi Innocenti, G Pratesi, L Azas, C Pratesi.   

Abstract

OBJECTIVES: The aim of the study was to evaluate early and mid-term results of surgical repair of isolated iliac artery aneurysm (IAA) in patients with non aneurysmal abdominal aorta.
METHODS: From January 1996 to December 2006, 34 patients with IAA had elective surgery. In 32 cases open repair was performed. Two patients had endovascular repair using a tube endoprosthesis and internal iliac artery coil embolization. The diameters of the abdominal aorta and iliac arteries were measured preoperatively and during follow-up. Early and late results in terms of mortality, major morbidity, reinterventions and graft-related complications were recorded. Mean pre and postoperative diameters of abdominal aorta were compared.
RESULTS: The site of the IAA was the common iliac artery in 29 cases (10 bilateral), internal iliac artery in 4 cases and external iliac artery in 1 case. Preoperative mean abdominal aortic diameter was 22.2mm (SD 7.6). There were no perioperative deaths and two major complications (retroperitoneal bleeding and limb ischemia) occurred. At the median follow-up time of 24 months survival was estimated as 91%. No reinterventions, graft thrombosis and graft related complications occurred. There were no cases of abdominal aorta aneurysm development. Mean aortic diameter at the most recent imaging was 23.1mm, which was not significantly different from preoperative values (p=0.2).
CONCLUSIONS: Surgical treatment of IAAs provides good early and mid-term results. During mid-term follow-up the diameter of abdominal aorta remains stable, suggesting IAA may be a localized aneurysmal disease.

Entities:  

Mesh:

Year:  2008        PMID: 18226565     DOI: 10.1016/j.ejvs.2007.11.017

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  7 in total

1.  The effect of endovascular treatment on isolated iliac artery aneurysm treatment and mortality.

Authors:  Dominique B Buck; Rodney P Bensley; Jeremy Darling; Thomas Curran; John C McCallum; Frans L Moll; Joost A van Herwaarden; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2015-05-02       Impact factor: 4.268

2.  Staged Endovascular Repair of Isolated Bilateral Internal Iliac Artery Aneurysms: A Case Report.

Authors:  Chrisostomos Maltezos; George Galyfos; Stavros Kerasidis; Georgios Geropapas; Nikolaos Makris
Journal:  Int J Angiol       Date:  2015-11-19

3.  A distinguished case of a spontaneously dissecting Left Common Iliac Artery Aneurysm, associated with an Elastinopathy, in a healthy 36-year-old male, successfully treated with open surgical repair - A Case Report.

Authors:  Omar Hariri; Omar Al Laham; Ammar Mohammad
Journal:  Int J Surg Case Rep       Date:  2022-05-30

4.  Comparison between endovascular repair and open surgery for isolated iliac artery aneurysms.

Authors:  Kimihiro Igari; Toshifumi Kudo; Takahito Toyofuku; Masatoshi Jibiki; Yoshinori Inoue
Journal:  Surg Today       Date:  2014-07-03       Impact factor: 2.549

5.  Complex common and internal iliac or aortoiliac aneurysms and current approach: individualised open-endovascular or combined procedures.

Authors:  Thomas Kotsis; Louizos Alexander Louizos; Evangelos Pappas; Kassiani Theodoraki
Journal:  Int J Vasc Med       Date:  2014-09-28

6.  CT-fusion-guided endovascular repair of iatrogenic common iliac artery aneurysm: A case report.

Authors:  Anton Khilchuk; Sergei Vlasenko; Musheg Muradyan; Maksim Agarkov; Dana Abdulkarim; Sergei Shcherbak; Dmitrii Gladyshev; Andrei Sarana; Sergei Litvinovskii; Vladislav Kovalik
Journal:  Radiol Case Rep       Date:  2019-09-18

7.  Endovascular Management of Giant Isolated Iliac Artery Aneurysms: A Case Series.

Authors:  Gönül Zeren; Fatma Can; İlhan İlker Avcı; Mustafa Azmi Sungur; Mehmet Fatih Yılmaz; Can Yücel Karabay
Journal:  Anatol J Cardiol       Date:  2022-09       Impact factor: 1.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.